atezolizumab
roche
['dante', 'atezo', 'gastric']
ph 2 dante: periop flot +/- atezo in resectable esophagogastric adenocarcinoma no difference in surgical morbidity path regression w/ atezo, particularly if higher pd-l1 msi-h group: trg1a 63% vs 27% ph 3 ongoing chemo needed in msi-h pts? #asco22 
??Medical Oncologist, MSc, PhD. GI/neuroendocrine/GU tumors/breast cancer ??Hospital Universitario UFC-CE, Oncologia D’Or